Paul Bulcke Kurt Schmidt Wan Ling Martello Chief Executive Head - - PowerPoint PPT Presentation

paul bulcke kurt schmidt wan ling martello chief
SMART_READER_LITE
LIVE PREVIEW

Paul Bulcke Kurt Schmidt Wan Ling Martello Chief Executive Head - - PowerPoint PPT Presentation

Paul Bulcke Kurt Schmidt Wan Ling Martello Chief Executive Head of Nestl Nutrition Chief Financial Officer Roddy Child-Villiers Head of Investor Relations 0 23 rd April, 2012 Pfizer Nutrition Acquisition Disclaimer This presentation


slide-1
SLIDE 1

23rd April, 2012 Pfizer Nutrition Acquisition

Kurt Schmidt Head of Nestlé Nutrition Wan Ling Martello Chief Financial Officer Paul Bulcke Chief Executive

Roddy Child-Villiers Head of Investor Relations

slide-2
SLIDE 2

23rd April, 2012 Pfizer Nutrition Acquisition

Disclaimer

This presentation contains forward looking statements which reflect Management’s current views and estimates. The forward looking statements involve certain risks and uncertainties that could cause actual results to differ materially from those contained in the forward looking

  • statements. Potential risks and uncertainties

include such factors as general economic conditions, foreign exchange fluctuations, competitive product and pricing pressures and regulatory developments.

1

slide-3
SLIDE 3

23rd April, 2012 Pfizer Nutrition Acquisition 2

Paul Bulcke Chief Executive

2

slide-4
SLIDE 4

23rd April, 2012 Pfizer Nutrition Acquisition

Building on... Our 145 year commitment Our Nutrition, Health & Wellness strategy Our special commitment to the first 1000 days

3

slide-5
SLIDE 5

23rd April, 2012 Pfizer Nutrition Acquisition 4

Building on our 145 year commitment...

Henri Nestlé

slide-6
SLIDE 6

23rd April, 2012 Pfizer Nutrition Acquisition

On our Nutrition, Health & Wellness strategy...

5

slide-7
SLIDE 7

23rd April, 2012 Pfizer Nutrition Acquisition

Operational Pillars Growth Drivers Competitive Advantages

6

Aligned with the Nestlé Roadmap

slide-8
SLIDE 8

23rd April, 2012 Pfizer Nutrition Acquisition 7

Aligned with the Nestlé Roadmap

60/40+ Nestlé R&D Nestlé Nutrition Nestlé Health Science,

Nestlé Institute of Health Sciences

Venture Funds M&A: Strategic

Cultural Financial

slide-9
SLIDE 9

23rd April, 2012 Pfizer Nutrition Acquisition 8

Building on our special commitment to the first 1000 days ...

slide-10
SLIDE 10

23rd April, 2012 Pfizer Nutrition Acquisition 9

Kurt Schmidt Global Head Nestlé Nutrition

9

slide-11
SLIDE 11

23rd April, 2012 Pfizer Nutrition Acquisition 10

The first 1000 days

Critical nutritional milestones from conception through infancy

Science-based education & services for the right nutritional choices Breastfeeding

The best form of nutrition in the first 6 months of life

The right start of a consumer journey with Nestlé Start Healthy Stay Healthy

slide-12
SLIDE 12

23rd April, 2012 Pfizer Nutrition Acquisition 11

Pfizer Nutrition... Strong fit with Nestlé

Strategic Cultural Financial

slide-13
SLIDE 13

23rd April, 2012 Pfizer Nutrition Acquisition

Infant Nutrition

Our roots & the core of Nutrition, Health & Wellness

Start of a new journey

Nestlé & Pfizer Nutrition nurturing a healthier generation

Building a strong future on our core passion & roots

Nutrition, Health & Wellness

12

slide-14
SLIDE 14

23rd April, 2012 Pfizer Nutrition Acquisition

Nestlé & Pfizer Nutrition

Strong fit in attractive category

13

Strengthened position & a winning combination

Infant Nutrition: High value & high growth Nestlé Nutrition: Category pioneer & global leader Pfizer Nutrition: Dynamic & valuable business with

exposure in growth markets

slide-15
SLIDE 15

23rd April, 2012 Pfizer Nutrition Acquisition

Infant Nutrition is an attractive category

Large market: ~USD 30 bn High growth: ~10% p.a. globally Emerging markets: 73% of market, 13% growth p.a.

–Increasing births –Increasing affluence –Increasing awareness of benefits of good nutrition –Premiumisation & broader range of product benefits

Source: Euromonitor (Milk Formula)

14

slide-16
SLIDE 16

23rd April, 2012 Pfizer Nutrition Acquisition

Infant Nutrition is highly dynamic

15

Source: Euromonitor (Milk Formula)

Egypt

(%)

slide-17
SLIDE 17

23rd April, 2012 Pfizer Nutrition Acquisition

Pfizer Nutrition

Dynamic player with strong geographic growth profile

85% of sales in emerging markets

– Key markets include: China, Philippines, Thailand, Indonesia, Middle East, Mexico

Strong reputation & equity with Health Care Professionals High quality brand portfolio with strength in premium products Strong leadership team with proven track record Good and consistent financial performance 5,400 employees, 5 factories and 3 R&D centres

16

slide-18
SLIDE 18

23rd April, 2012 Pfizer Nutrition Acquisition

Nestlé & Pfizer Nutrition

Building on Nestlé’s strong base

17

Nestlé Infant Nutrition today:

Global leadership with broad geographic reach Leading global R&D network Strong medical & scientific partnerships Science-based innovation Focused stand-alone organisation

slide-19
SLIDE 19

23rd April, 2012 Pfizer Nutrition Acquisition

Nestlé Nutrition & Pfizer Nutrition

Enhanced presence in dynamic regions

18

Top 10 markets:

9 markets in the world’s top 10 of highest absolute population growth 45%+ of the next 5 years’ category growth will come from China/HK*

*Euromonitor (Milk Formula)

Nestlé IF & GUMs Nestlé IF & GUMs & Pfizer Nutrition Sales 2011 USD 5bn+ USD 7bn+ % in Emerging Markets 83% 85% % in Asia, Oceania & Africa 45% 55% % in Leading Positions 65% 75%

slide-20
SLIDE 20

23rd April, 2012 Pfizer Nutrition Acquisition

Complementary benefits & platforms

Strength from entry level to super premium

19

Picky Eater Immune Protection Gut Comfort Optimal growth & Development Brain Development

Enlarged business has a pioneering presence in key benefit platforms Strong presence in premium & super-premium products

Allergy Prevention

slide-21
SLIDE 21

23rd April, 2012 Pfizer Nutrition Acquisition 20

Nestlé Nutrition & Pfizer Nutrition

Strong cultural fit

Combined management teams with sustained, successful track record Leadership teams focused on science-based innovation Consistent focus on compliance, quality & safety; ‘non-negotiable’ Conviction that ‘breast-feeding is best’ Ethical approach to marketing

slide-22
SLIDE 22

23rd April, 2012 Pfizer Nutrition Acquisition

Summary

A great fit with capabilities & presence to win

Enhances strong Nestlé business Positions Nestlé to benefit from population growth Expands our portfolio Leverages R&D:

Nestlé’s into Pfizer Nutrition brands; Pfizer Nutrition’s into Nestlé brands

Combines strong management teams Benefits from ‘Nestlé in the Market’ scale, capabilities, systems, etc.

21

slide-23
SLIDE 23

23rd April, 2012 Pfizer Nutrition Acquisition 22

Wan Ling Martello Chief Financial Officer

22

slide-24
SLIDE 24

23rd April, 2012 Pfizer Nutrition Acquisition

Pfizer Nutrition

23

A high quality business Accretive to Nestlé Model Implementing Nestlé acquisition strategy

Creating shareholder value over time by enhancing our positions & capabilities to win in the world’s most dynamic markets

slide-25
SLIDE 25

23rd April, 2012 Pfizer Nutrition Acquisition

Pfizer Nutrition – a high quality business

A track-record of dynamic growth

24

Sales 2009-2012 (USD bn)

CAGR: +13%

2012E Sales: USD 2.4bn

85% of which in Emerging Markets

1.6 1.9 2.2 2.4 2009 2010 2011 2012E

2012: Nestlé estimate

slide-26
SLIDE 26

23rd April, 2012 Pfizer Nutrition Acquisition

Pfizer Nutrition – a high quality business

Healthy level of profitability

25

A proven track-record of profitable growth

EBITDA & EBITDA margin 2009-2012 (USD bn)

0.4 0.4 0.5 0.6 25% 23% 25% 25% 2009 2010 2011 2012E

2012: Nestlé estimate

slide-27
SLIDE 27

23rd April, 2012 Pfizer Nutrition Acquisition

Key transaction parameters

Acquisition price:

USD 11.85 bn

Multiple (EV/EBITDA 2012E):

19.8x 15.6x post run rate synergies

Full year cost synergies:

USD 160 mn

Financing:

Cash & additional debt, strong balance sheet maintained

Closing subject to regulatory approvals

26

2012: Nestlé estimate

slide-28
SLIDE 28

23rd April, 2012 Pfizer Nutrition Acquisition

Pfizer Nutrition accretive to the Nestlé Model

Organic Growth:

Above Group’s 5-6% OG guidance

Margin:

Immediate

EPS:

First full year

Capital Efficiencies:

ROIC to exceed cost of capital in year 4 to 5

27

slide-29
SLIDE 29

23rd April, 2012 Pfizer Nutrition Acquisition

Implementing Nestlé’s acquisition strategy

Strategic To be a category leader

  • Leading positions globally

Focused approach on value-added growth categories

  • Category growing at 10%

Strong brands in leadership positions

  • High quality brands, strong market

positions Cultural High degree of certainty of successful integration

  • Operations complementary,

good cultural fit Financial Generate value for shareholders

  • Growth model & healthy returns

Top & bottom line, & cash flow enhancing

  • Accretive

Maintain strong credit ratings & financial flexibility

  • Strong credit ratings maintained

28

slide-30
SLIDE 30

23rd April, 2012 Pfizer Nutrition Acquisition 29

... captures the very essence

  • f Nestlé and the promise

we commit ourselves to everyday, everywhere as the leading Nutrition, Health and Wellness Company